tiprankstipranks
Trending News
More News >
Waverley Pharma (TSE:WAVE)
:WAVE
Advertisement

Waverley Pharma (WAVE) Price & Analysis

Compare
5 Followers

WAVE Stock Chart & Stats


WAVE FAQ

What was Waverley Pharma’s price range in the past 12 months?
Waverley Pharma lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
    What is Waverley Pharma’s market cap?
    Waverley Pharma’s market cap is C$810.00K.
      When is Waverley Pharma’s upcoming earnings report date?
      Waverley Pharma’s upcoming earnings report date is Apr 23, 2026 which is in 231 days.
        How were Waverley Pharma’s earnings last quarter?
        Waverley Pharma released its earnings results on Aug 21, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
          Is Waverley Pharma overvalued?
          According to Wall Street analysts Waverley Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Waverley Pharma pay dividends?
            Waverley Pharma does not currently pay dividends.
            What is Waverley Pharma’s EPS estimate?
            Waverley Pharma’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Waverley Pharma have?
            Waverley Pharma has 54,000,000 shares outstanding.
              What happened to Waverley Pharma’s price movement after its last earnings report?
              Waverley Pharma reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Waverley Pharma?
                Currently, no hedge funds are holding shares in TSE:WAVE

                Company Description

                Waverley Pharma

                Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide. It is also developing WAV-101 and WAV-102 products for the treatment of cancer. Geographically, it derives revenue from the United Kingdom.

                Waverley Pharma (WAVE) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                NanoSphere Health Sciences Inc
                Biocure Technology Inc
                Albert Labs International
                Vaxil Bio
                WPD Pharmaceuticals
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis